Cargando…

A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe

INTRODUCTION: A real-world study was performed to describe the clinical characteristics of patients who received dapagliflozin to better understand differences when initiating dapagliflozin in various countries and different prescribing settings. METHODS: We assessed pooled data from observational s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fadini, Gian Paolo, Tentolouris, Nikolaos, Caballero Mateos, Irene, Bellido Castañeda, Virginia, Morales Portillo, Cristóbal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995805/ https://www.ncbi.nlm.nih.gov/pubmed/31863344 http://dx.doi.org/10.1007/s13300-019-00744-6

Ejemplares similares

Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis
por: Fadini, Gian Paolo, et al.
Publicado: (2022)

Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study
por: Morales, Cristóbal, et al.
Publicado: (2022)

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

The multinational enterprise, EU enlargement and Central Europe : the effects of regulatory convergence /
por: Akbar, Yusaf H., 1969-
Publicado: (2003)

Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
por: Bonora, Benedetta Maria, et al.
Publicado: (2019)

Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
por: Bellido, Virginia, et al.
Publicado: (2022)

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF
por: McEwan, Phil, et al.
Publicado: (2020)

Phylogeny of saprobic microfungi from Southern Europe
por: Hernández-Restrepo, M., et al.
Publicado: (2017)

Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe
por: Deberdt, Walter, et al.
Publicado: (2015)

Similar effectiveness of dapagliflozin and GLP‐1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2019)

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
por: Götzinger, Florian, et al.
Publicado: (2020)

Innovative Methods Used in Monitoring COVID-19 in Europe: A Multinational Study
por: Unim, Brigid, et al.
Publicado: (2022)

Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
por: Fadini, Gian Paolo, et al.
Publicado: (2017)

Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
por: Håkansson, Erik, et al.
Publicado: (2021)

A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
por: Kim, Hyun Chul, et al.
Publicado: (2023)

Multinational outbreak of travel-related Salmonella Chester infections in Europe, summers 2014 and 2015
por: Fonteneau, Laure, et al.
Publicado: (2017)

Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study
por: Warris, Adilia, et al.
Publicado: (2020)

Multinationals and transition : business strategies, technology, and transformation in Central and Eastern Europe /
por: Manea, Julia
Publicado: (2004)

Cost-effectiveness analysis of dapagliflozin for the treatment of type 2 diabetes mellitus in Spain: results of the DECLARE-TIMI 58 study
por: Escobar, Carlos, et al.
Publicado: (2022)

Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea
por: Jaffuel, Dany, et al.
Publicado: (2023)

Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe
por: Willems, Damon, et al.
Publicado: (2023)

Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study
por: Maghnie, Mohamad, et al.
Publicado: (2023)

Technology and the multinationals : Corporate strategies in a changing world economy
por: Baranson, Jack
Publicado: (1979)

Dog rabies data reported to multinational organizations from Southern and Eastern African countries
por: Beyene, Tariku Jibat, et al.
Publicado: (2017)

The degree of internationalization of Chinese Multinationals along the belt and road initiative countries
por: Adedigba, Olawoyin Gregory, et al.
Publicado: (2020)

Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
por: Han, Eugene, et al.
Publicado: (2018)

Multinational democracies /
Publicado: (2001)

Multinational corporations
Publicado: (1990)

The multinational corporation
por: Liebenau, Jonathan
Publicado: (1984)

Multinational Telecommunications
por: Collective
Publicado: (1977)

Perioperative Outcomes of Primary Bariatric Surgery in North-Western Europe: a Pooled Multinational Registry Analysis
por: Poelemeijer, Youri Q. M., et al.
Publicado: (2018)

Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe
por: Fortuny, Joan, et al.
Publicado: (2021)

Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study
por: Nijman, Ruud G., et al.
Publicado: (2022)

Surveying immigrants in Southern Europe: Spanish and Italian strategies in comparative perspective
por: Serrano Sanguilinda, Inmaculada, et al.
Publicado: (2017)

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study
por: Morieri, M. L., et al.
Publicado: (2023)

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
por: List, James F., et al.
Publicado: (2009)

Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors
por: Fadini, Gian Paolo, et al.
Publicado: (2021)

Not so critical appraisal of dapagliflozin
por: Doggrell, Sheila A
Publicado: (2014)

Drivers of phenological changes in southern Europe
por: Vogel, Johannes
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ddvqoq5fk6v3trispfrvohg5fh